InvestorsHub Logo
Followers 618
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: TimetoRetire post# 93190

Monday, 03/02/2015 3:58:13 PM

Monday, March 02, 2015 3:58:13 PM

Post# of 402174
Tremendous follow through overall.

Just a few actions I consider major due to lack of time for searching at the moment:

9.9.13 http://cellceutix.com/cellceutix-acquires-polymedix-assets-from-bankruptcy-court-gains-ownership-of-two-clinical-stage-drugs-multiple-compounds-and-equipment-assets/#sthash.erUO8KJH.dpbs

$CTIX acted quickly on the new acquisitions. They have already completed a phase 2b trial on the newly acquired Brilacidin.

1.5.15 http://cellceutix.com/cellceutix-releases-confidence-interval-statistics-showing-clinical-success-rates-for-brilacidin-in-treatment-of-absssi/#sthash.7LAhMbZr.dpbs

Current trials: https://clinicaltrials.gov/ct2/results?term=cellceutix

Look at the portfolio of drugs: http://cellceutix.com/pipeline/#sthash.d0XjEoxn.dpbs

Look at the chart:







In Reply to 'TimetoRetire'
Too much hype with extremely little follow through in the last couple years.I think Leo is starting to be laughed at by the majority of onlookers including FDA,big Pharma and institutions that may be looking. He has put out too many meaningless pr's and everyone is getting numb to it. I have a lot of money tied up in this company and starting to wonder if Leo is just a super hero in his own eyes. Today's Pr was basically pathetic when he knows his company will be chewed up and spit out unless he gets his act together. This Pr was about something that may happen 3 years out. What about the important stuff that everyone has been essentially promised for the last 3 years Leo? Sorry guys, this is the truth wether it wants to be heard or not. ..





To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News